Search results
Q2 2024 EPS Estimates for Viking Therapeutics, Inc. Lowered by HC Wainwright (NASDAQ:VKTX)
ETF DAILY NEWS· 5 days agoViking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at HC Wainwright cut their Q2 2024 earnings estimates for Viking Therapeutics in a research report issued ...
Viking Therapeutics CFO sells over $4.9 million in company stock By Investing.com
Investing.com· 1 day agoIn a recent transaction, Greg Zante, the Chief Financial Officer of Viking Therapeutics, Inc....
Check Out What Whales Are Doing With VKTX - Viking Therapeutics (NASDAQ:VKTX)
Benzinga· 5 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Viking Therapeutics . Looking at options history for Viking Therapeutics VKTX< ...
Q4 2024 Earnings Forecast for Viking Therapeutics, Inc. (NASDAQ:VKTX) Issued By Leerink Partnrs
ETF DAILY NEWS· 6 days agoViking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Stock analysts at Leerink Partnrs lifted their Q4 2024 EPS estimates for Viking Therapeutics in a report released on ...
Brokers Issue Forecasts for Viking Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:VKTX)
ETF DAILY NEWS· 5 days agoViking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Stock analysts at William Blair increased their Q2 2024 EPS estimates for Viking Therapeutics in a research report ...
Can This High-Flying Stock 10x in 10 Years?
Motley Fool via Yahoo Finance· 7 days agoViking Therapeutics (NASDAQ: VKTX) has been flying on all cylinders since the beginning of the year. The company's shares are up 246% due to excellent...
Is Viking Therapeutics Incredibly Undervalued?
Motley Fool via Yahoo Finance· 7 days agoViking Therapeutics (NASDAQ: VKTX) has emerged as a beacon of hope in an otherwise lackluster year for healthcare stocks. The buzz around its mid-stage...
Viking Therapeutics COO sells shares worth over $22 million By Investing.com
Investing.com· 2 days agoMarianna Mancini, the Chief Operating Officer of Viking Therapeutics, Inc. (NASDAQ:VKTX), has...
Oppenheimer reiterates Viking Therapeutics Inc
Knox Daily· 4 days agoAs a result of the transaction, Rouan Sarah Kathryn now holds 0 shares, worth roughly $0.0. Oppenheimer reiterated its Viking Therapeutics Inc [VKTX] rating to an Outperform ...
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
InvestorPlace· 3 days agoWhile a weakening economy and a subsequent dip in the stock market are unfortunate, they are...